Michael D. Roth
David Geffen School of Medicine
University of California
Los Angeles
Name/email consistency: high
- Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease. Roth, M.D., Tseng, C.H., Clements, P.J., Furst, D.E., Tashkin, D.P., Goldin, J.G., Khanna, D., Kleerup, E.C., Li, N., Elashoff, D., Elashoff, R.M. Arthritis Rheum. (2011)
- Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. Roth, M.D., Tashkin, D.P., Choi, R., Jamieson, B.D., Zack, J.A., Baldwin, G.C. J. Infect. Dis. (2002)
- Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses. Roth, M.D., Cheng, Q., Harui, A., Basak, S.K., Mitani, K., Low, T.A., Kiertscher, S.M. J. Immunol. (2002)
- Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Roth, M.D., Baldwin, G.C., Tashkin, D.P. Chem. Phys. Lipids (2002)
- Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Roth, M.D., Marques-Magallanes, J.A., Yuan, M., Sun, W., Tashkin, D.P., Hankinson, O. Am. J. Respir. Cell Mol. Biol. (2001)
- Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients. Roth, M.D., Gitlitz, B.J., Kiertscher, S.M., Park, A.N., Mendenhall, M., Moldawer, N., Figlin, R.A. Cancer Res. (2000)